Taro Pharmaceuticals to pay more than $200 million to settle U.S. price-fixing probe – Reuters India
Taro Pharmaceutical agreed to pay more than $200 million to settle allegations that it conspired to fix the prices of generic drugs, the Justice Department said on Thursday.
